About Amdipharm Mercury
Amdipharm Mercury is a company based in London (United Kingdom) founded in 2013 was acquired by Concordia International in September 2015. Amdipharm Mercury has completed 1 acquisition, including Focus Pharmaceuticals.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Concordia International
(Sep 08, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Amdipharm Mercury
Detailed funding history for Amdipharm Mercury
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Amdipharm Mercury
Amdipharm Mercury has secured backing from 1 investor. Prominent investors backing the company include Concordia International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Distributes specialty pharmaceutical drugs to healthcare providers.
|
Locked | Locked | Locked |
Investor details for Amdipharm Mercury
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amdipharm Mercury
Amdipharm Mercury has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Focus Pharmaceuticals.
Investment portfolio details for Amdipharm Mercury
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Geospatial data and aerial imagery services are provided globally.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Amdipharm Mercury
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Amdipharm Mercury
Detailed financials for Amdipharm Mercury
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amdipharm Mercury Comparisons
Peer comparison for Amdipharm Mercury
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amdipharm Mercury
Detailed competitors of Amdipharm Mercury
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amdipharm Mercury
Complete news archive for Amdipharm Mercury
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amdipharm Mercury
Amdipharm Mercury was founded in 2013.
Amdipharm Mercury is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Amdipharm Mercury was founded in 2013 in London, United Kingdom, and is focused on legacy pharmaceutical products and orphan drugs. The company emerged from the acquisition of the AMCo group by Concordia International Corp in 2015. A broad portfolio of niche medicines is maintained and distributed through four ranges: Amdipharm, Mercury Pharma, Abcur, and Focus products.
Amdipharm Mercury has made 1 acquisition, including Focus Pharmaceuticals.
Amdipharm Mercury has 1 investor. Key investors include Concordia International.